NeoImmuneTech

Leadership team

Se Hwan Yang (President, CEO & Chairman)

Soo-Hyoung Kang (Director)

Jung Won Woo (Director)

Products/ Services

Biotechnology, Health Care, Therapeutics

Number of Employees

50 - 100

Headquarters

Seongnam, Kyonggi-do, South Korea

Established

2014

Traded as

KOSDAQ:950220

URL

neoimmunetech.com/

Overview

Location

Recognition and Award

References

Summary

NeoImmuneTech is a biotechnology company dedicated to the research and development of novel immunotherapies and cancer treatments.

History

NeoImmuneTech was founded in California in 2012 by medical researchers from the University of California, San Francisco and Stanford University. It was funded by a successful series of venture capital rounds and several private investors. The company has since grown to over 150 employees in five locations around the world.

Mission

Our mission is to develop innovative immunotherapy technologies to treat serious diseases and improve the quality of life for patients.

Vision

Our vision is to be the global leader in the development and commercialization of novel immunotherapies that save and improve the lives of people around the world.

Key Team

Rafi Ahmed (Member of Scientific Advisory Board)

Richard Kim (Member of Scientific Advisory Board)

Keith Watson (Member of Scientific Advisory Board)

Byoung Jo Kang (Director)

Young Kwang Chae (Member of Scientific Advisory Board)

Jin-Hyoung Kang (Director)

Hyunseok Kang (Member of Scientific Advisory Board)

Recognition and Awards

NeoImmuneTech has been the recipient of numerous awards, including the National Institutes of Health's Transformative Research Award, Forbes' Up and Comer Award, and a Golden Goose Award.